Palatin Technologies, Inc.
Melanocortin-1 Receptor-Specific Peptides for Cytokine Storm and Inflammation Therapy
Last updated:
Abstract:
Methods preventing, ameliorating or treating cytokine storm or inflammatory disease, indications, conditions and syndromes by administration of a therapeutically effective amount of a melanocortin-1 receptor-specific cyclic peptide or pharmaceutically acceptable salt thereof.
Status:
Application
Type:
Utility
Filling date:
13 Jul 2020
Issue date:
29 Oct 2020